Navigation Links
Cadila to Commence Phase I Clinical Trials On ZYH2

Cadila Healthcare Ltd today said it has received approval from Drug Controller General of India (DCGI) to conduct Phase I clinical trials on its New Molecular Entity// (NME) - ZYH2, used for treating diabetes.

In pre-clinical studies on 'ZY H2' displayed that it has the potential to improve insulin resistance and lower blood glucose in diabetic conditions without causing hypoglycemia, the company informed the Bombay Stock Exchange.

It also works favourably to lower the elevated lipid levels and the pre-clinical studies on ZYH2 indicate that this NME may be more effective for diabetics, it added.

The shares of the company closed at Rs 545.50, up 0.06 per cent at the BSE.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Zydus Cadila and Kopran in strategic alliance
2. Cadila gets US FDA approval for Promethazine tablets
3. Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
4. Face Transplants To Commence In The UK
5. Pfizer Commences Its Advertising for Celebrex with All the Warnings
6. Natco Pharma Commences Production At Dehradun Unit
7. Chinas First Gay Health Clinic Commences Operations
8. Mental Health - NHS Trust Commences Specialist Transition Service
9. SARS-Free Taiwan to Mark End Phase of Global Fight
10. Spray on contraceptive clears Phase I trial
11. Phase 3 trials of two multi-kinase inhibitors against cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/20/2017)... Petersburg, Fla. (PRWEB) , ... February 20, 2017 , ... ... its research and education building. A topping out ceremony on Friday marked the halfway ... The building, set to open in Fall 2018, will serve as a center for ...
(Date:2/20/2017)... ... February 20, 2017 , ... Today, Illuma Care Connections, ... announced during the 2017 Annual HIMSS Conference & Exhibition in Orlando, ... patients and integrating eye care into mainstream healthcare delivery is powered by ...
(Date:2/19/2017)... ... 19, 2017 , ... The Citadel’s new Swain Department of Nursing , ... Amelia Joseph, Ph.D. Joseph was engaged by the college as a consultant to help ... 2016. After a nation-wide search, she was selected to head the department as nurse ...
(Date:2/19/2017)... ... ... ProBrand Glitch is a set of 30 glitch distortion logo reveals made exclusively for ... with a glitch reveal in just a few clicks of a mouse. Customizable glitch style ... preset. Use these presets to add a uniquely animated logo to any photos or videos. ...
(Date:2/19/2017)... ... February 19, 2017 , ... Orbita, ... will join forces with Healthwise ® at HIMSS 2017 to ... leader in evidence-based health education, technology and services, will demonstrate a voice-powered knowedge ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, ... is expected to grow at a CAGR of 9.4% from 2017-2022 ... grow at a CAGR of 9.5% from 2017 to 2027. The ... ... will benefit you Read on to discover how you can ...
(Date:2/17/2017)... , Feb. 17, 2017 Arvinas LLC, ... drugs based on protein degradation, today announced the presentation ... (AR) PROTAC during a poster session at the American ... GU) in Orlando, FL. ... validate our platform and the potential of PROTACs to ...
(Date:2/17/2017)... , Feb 17, 2017 Research and Markets has ... Business Report" report to their offering. ... The report provides separate comprehensive analytics for the US, ... , Asia-Pacific , and Rest of World. Annual ... a six-year historic analysis is provided for these markets. Market data and ...
Breaking Medicine Technology: